FDA 483 OBSERVATION · #168 OF 1,945 MOST-CITED

Complete test data included in records

FDA cited this observation 189 times across 175 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs189
BY FISCAL YEAR
FY202611
FY202514
FY202418
FY202312
FY20228
FY202111
FY20208
FY201925
FY201826
FY201732
FY201624

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 5.4× the rate of the average FDA-cited firm (42.3% vs 7.8%), across 175 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Steril-Gene Life Sciences Private Ltd · Puducherry · Drugs · 2026-08-12

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Bushu Pharmaceuticals Ltd. · Kawagoe · Drugs · 2026-08-03

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Pace Analytical Life Sciences, LLC · Oakdale, Minnesota · Drugs · 2026-05-29

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Canyon Rush, LLC · Rush, New York · Drugs · 2026-05-15

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Alcami Carolinas Corporation · Charleston, South Carolina · Drugs · 2026-04-22

Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.

Rohto-Mentholatum (Vietnam) Co., Ltd. · Ho Chi Minh · Drugs · 2026-04-14

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →